We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Visit the UK for medical treatment - check if you’re eligible and if you need a visa, what visa to apply for, what to do when you travel to the UK.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
Help available and steps you should take if you have a medical emergency or are hospitalised abroad, including for planned treatment.
As with any medicine, the MHRA will keep the safety and effectiveness of Vyjuvek under close review.
This page is designed to provide British Nationals with an overview of medical treatment in China and information on how the FCDO can help if a British National is in hospital.
Tax and reporting rules for employers providing medical or dental treatment and insurance.
Amiodarone has been associated with serious and potentially life-threatening side effects, particularly of the lung, liver, and thyroid gland. We remind healthcare professionals that patients should be supervised and reviewed regularly during treatment. Lung problems may have slow onset but...
Preventing people in England from developing high blood pressure (hypertension), and detecting and managing it better in those who have it.
MHRA approves donidalorsen (Dawnzera) for the treatment of hereditary angioedema
The MHRA launches public consultation on new framework that could lead to earlier licensing for therapies for up to 3.5 million people in the UK.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).